PHF2 Destabilizes NFATc1 to Curb Osteoclast Formation and Bone Loss
Researchers identify PHF2 as a post-translational brake that destabilizes NFATc1 through hydroxylation to limit osteoclast differentiation and bone loss.
Researchers identify PHF2 as a post-translational brake that destabilizes NFATc1 through hydroxylation to limit osteoclast differentiation and bone loss.
Researchers found that Dhx36 modulates a promoter G-quadruplex to activate Alpl transcription and restore bone mass in osteoporotic mice.
New research identifies macrophages as key mediators linking aging and osteoporosis, revealing a bidirectional causal relationship driven by shared genetic ...
In dexamethasone-treated bone marrow mesenchymal stem cells, researchers identified neoeriocitrin as an mTORC1-targeting citrus flavonoid that restores osteogenic differentiation by ...
A comprehensive review finds gut microbiota shifts correlate with bone loss, but clinical evidence fails to prove probiotics prevent osteoporotic ...
A study in BMC Immunology links Helicobacter pylori infection to higher osteoporosis risk, mediated by a Th1-dominant immune shift.
Researchers have identified MBD3 and its D246 residue as key regulators promoting Runx2 deacetylation and osteoblast dysfunction in glucocorticoid-induced osteoporosis.
A psychological network study of 634 Saudi adults living with osteoporosis identified key central and bridging connections between emotional distress, ...
A retrospective study demonstrated that computed tomography body-composition metrics and clinical features accurately predict major pathological response to neoadjuvant immunochemotherapy ...
Researchers developed chondroitin sulfate-decorated gold nanoparticles that alleviated osteoporosis in ovariectomized rats by suppressing MAPK phosphorylation and rebalancing gut microbiota.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine